From pathway to population - a multiscale model of juxtacrine EGFR-MAPK signalling

被引:15
|
作者
Walker, D. C. [1 ]
Georgopoulos, N. T. [2 ]
Southgate, J. [2 ]
机构
[1] Univ Sheffield, Dept Comp Sci, Kroto Res Inst, Sheffield S3 7HQ, S Yorkshire, England
[2] Univ York, Jack Birch Unit Mol Carcinogenesis, Dept Biol, York YO10 5YW, N Yorkshire, England
来源
BMC SYSTEMS BIOLOGY | 2008年 / 2卷
基金
英国工程与自然科学研究理事会;
关键词
D O I
10.1186/1752-0509-2-102
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Most mathematical models of biochemical pathways consider either signalling events that take place within a single cell in isolation, or an 'average' cell which is considered to be representative of a cell population. Likewise, experimental measurements are often averaged over populations consisting of hundreds of thousands of cells. This approach ignores the fact that even within a genetically-homogeneous population, local conditions may influence cell signalling and result in phenotypic heterogeneity. We have developed a multi-scale computational model that accounts for emergent heterogeneity arising from the influences of intercellular signalling on individual cells within a population. Our approach was to develop an ODE model of juxtacrine EGFR-ligand activation of the MAPK intracellular pathway and to couple this to an agent-based representation of individual cells in an expanding epithelial cell culture population. This multi-scale, multi-paradigm approach has enabled us to simulate Extracellular signal-regulated kinase (Erk) activation in a population of cells and to examine the consequences of interpretation at a single cell or population-based level using virtual assays. Results: A model consisting of a single pair of interacting agents predicted very different Erk activation (phosphorylation) profiles, depending on the formation rate and stability of intercellular contacts, with the slow formation of stable contacts resulting in low but sustained activation of Erk, and transient contacts resulting in a transient Erk signal. Extension of this model to a population consisting of hundreds to thousands of interacting virtual cells revealed that the activated Erk profile measured across the entire cell population was very different and may appear to contradict individual cell findings, reflecting heterogeneity in population density across the culture. This prediction was supported by immunolabelling of an epithelial cell population grown in vitro, which confirmed heterogeneity of Erk activation. Conclusion: These results illustrate that mean experimental data obtained from analysing entire cell populations is an oversimplification, and should not be extrapolated to deduce the signal: response paradigm of individual cells. This multi-scale, multi-paradigm approach to biological simulation provides an important conceptual tool in addressing how information may be integrated over multiple scales to predict the behaviour of a biological system.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] EGFR-MAPK pathway activation in human papillomavirus infected cells
    Barraza, Pamela
    Ozbun, Michelle
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [2] Targeted Quantification of Phosphorylation Dynamics in the Context of EGFR-MAPK Pathway
    Yi, Lian
    Shi, Tujin
    Gritsenko, Marina A.
    Chan, Chi-Yuet X'avia
    Fillmore, Thomas L.
    Hess, Becky M.
    Swensen, Adam C.
    Liu, Tao
    Smith, Richard D.
    Wiley, H. Steven
    Qian, Wei-Jun
    [J]. ANALYTICAL CHEMISTRY, 2018, 90 (08) : 5256 - 5263
  • [3] Conservation of protein abundance patterns reveals the regulatory architecture of the EGFR-MAPK pathway
    Shi, Tujin
    Niepel, Mario
    McDermott, Jason E.
    Gao, Yuqian
    Nicora, Carrie D.
    Chrisler, William B.
    Markillie, Lye M.
    Petyuk, Vladislav A.
    Smith, Richard D.
    Rodland, Karin D.
    Sorger, Peter K.
    Qian, Wei-Jun
    Wiley, H. Steven
    [J]. SCIENCE SIGNALING, 2016, 9 (436)
  • [4] Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway
    Zhang, Xiaojian
    Liu, Kun
    Zhang, Tao
    Wang, Zhenlei
    Qin, Xuan
    Jing, Xiaoqian
    Wu, Haoxuan
    Ji, Xiaopin
    He, Yonggang
    Zhao, Ren
    [J]. ONCOTARGET, 2017, 8 (01) : 1541 - 1554
  • [5] Adaptive ERK signalling activation in response to therapy and in silico prognostic evaluation of EGFR-MAPK in HNSCC
    Rong, Chao
    Muller, Marie F.
    Xiang, Fang
    Jensen, Alexandra
    Weichert, Wilko
    Major, Gerald
    Plinkert, Peter K.
    Hess, Jochen
    Affolter, Annette
    [J]. BRITISH JOURNAL OF CANCER, 2020, 123 (02) : 288 - 297
  • [6] Adaptive ERK signalling activation in response to therapy and in silico prognostic evaluation of EGFR-MAPK in HNSCC
    Chao Rong
    Marie F. Muller
    Fang Xiang
    Alexandra Jensen
    Wilko Weichert
    Gerald Major
    Peter K. Plinkert
    Jochen Hess
    Annette Affolter
    [J]. British Journal of Cancer, 2020, 123 : 288 - 297
  • [7] Cucurbitacin IIa interferes with EGFR-MAPK signaling pathway leads to proliferation inhibition in A549 cells
    Zhang, Jie
    Song, Yifan
    Liang, Yuan
    Zou, Haoyang
    Zuo, Peng
    Yan, Mi
    Jing, Siyuan
    Li, Tiezhu
    Wang, Yongjun
    Li, Da
    Zhang, Tiehua
    Wei, Zhengyi
    [J]. FOOD AND CHEMICAL TOXICOLOGY, 2019, 132
  • [8] Estrone analogs as potential inhibitors targeting EGFR-MAPK pathway in non-small-cell lung cancer
    Acheampong, Felix
    Ostlund, Trevor
    Mahnashi, Mater
    Halaweish, Fathi
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2023, 101 (06) : 1356 - 1366
  • [9] Icariin and icaritin stimulate the proliferation of SKBr3 cells through the GPER1-mediated modulation of the EGFR-MAPK signaling pathway
    Ma, Hai-Rong
    Wang, Jie
    Chen, Yiu-Fai
    Chen, Hua
    Wang, Wei-Shan
    Aisa, Haji Akber
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 33 (06) : 1627 - 1634
  • [10] Molecular Role of EGFR-MAPK Pathway in Patchouli Alcohol- Induced Apoptosis and Cell Cycle Arrest on A549 Cells In Vitro and In Vivo
    Lu, XinGang
    Yang, Liu
    Lu, ChengHua
    Xu, ZhenYu
    Qiu, HongFu
    Wu, JiaJia
    Wang, JingWen
    Tong, JiaFeng
    Zhu, Yin
    Shen, Jie
    [J]. BIOMED RESEARCH INTERNATIONAL, 2016, 2016